- Home
- MEC vs GOSS Comparison
MEC vs GOSS Comparison
Compare MEC & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- GOSS
- Stock Information
- Founded
- MEC 1945
- GOSS 2015
- Country
- MEC United States
- GOSS United States
- Employees
- MEC N/A
- GOSS N/A
- Industry
- MEC Industrial Specialties
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- GOSS Health Care
- Exchange
- MEC Nasdaq
- GOSS Nasdaq
- Market Cap
- MEC 329.4M
- GOSS 347.8M
- IPO Year
- MEC 2019
- GOSS 2019
- Fundamental
- Price
- MEC $14.60
- GOSS $2.47
- Analyst Decision
- MEC Strong Buy
- GOSS Strong Buy
- Analyst Count
- MEC 3
- GOSS 4
- Target Price
- MEC $21.33
- GOSS $8.50
- AVG Volume (30 Days)
- MEC 161.8K
- GOSS 3.1M
- Earning Date
- MEC 08-05-2025
- GOSS 08-05-2025
- Dividend Yield
- MEC N/A
- GOSS N/A
- EPS Growth
- MEC 64.18
- GOSS N/A
- EPS
- MEC 0.86
- GOSS N/A
- Revenue
- MEC $524,606,000.00
- GOSS $40,237,000.00
- Revenue This Year
- MEC N/A
- GOSS N/A
- Revenue Next Year
- MEC $17.38
- GOSS $30.65
- P/E Ratio
- MEC $17.07
- GOSS N/A
- Revenue Growth
- MEC N/A
- GOSS N/A
- 52 Week Low
- MEC $11.72
- GOSS $0.66
- 52 Week High
- MEC $23.02
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- MEC 46.47
- GOSS 68.08
- Support Level
- MEC $14.22
- GOSS $2.38
- Resistance Level
- MEC $14.80
- GOSS $2.65
- Average True Range (ATR)
- MEC 0.50
- GOSS 0.15
- MACD
- MEC 0.07
- GOSS 0.03
- Stochastic Oscillator
- MEC 57.65
- GOSS 76.67
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.